David Garofalo

Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

Manish B. Patel, Sandra Margunato‐Debay, L. Lal, 2017, Lung Cancer.

Clinical benefit of treatment with eribulin mesylate for metastatic triple‐negative breast cancer: Long‐term outcomes of patients treated in the US community oncology setting

B. Feinberg, J. Kish, S. Mougalian, 2018, Cancer medicine.

Real-world data analysis of ovarian cancer (OC) maintenance utilization among maintenance eligible patients.

H. J. Gierman, Greg B. Brown, Jeffrey A. Scott, 2019, Journal of Clinical Oncology.